| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/30/2004 | EP1432991A1 Identification and isolation of somatic stem cells and uses thereof |
| 06/30/2004 | EP1432819A2 Method for determining cell cycle position |
| 06/30/2004 | EP1432811A1 Cell separation matrix |
| 06/30/2004 | EP1432807A2 Induction of gene expression by silencing of repressor genes |
| 06/30/2004 | EP1432803A2 Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity |
| 06/30/2004 | EP1432801A2 Receptors and membrane-associated proteins |
| 06/30/2004 | EP1432799A2 Silencing of gene expression by sirna |
| 06/30/2004 | EP1432798A2 Self-processing plants and plant parts |
| 06/30/2004 | EP1432794A2 Human coagulation factor vii polypeptides |
| 06/30/2004 | EP1432792A2 Histone deacetylase 9 |
| 06/30/2004 | EP1432791A1 Alphavirus replicon vector systems |
| 06/30/2004 | EP1432790A1 Regulation of cytotrophoblast cell differentiation and cell migration |
| 06/30/2004 | EP1432736A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 06/30/2004 | EP1432732A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/30/2004 | EP1432722A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/30/2004 | EP1432448A2 Novel molecules of the hkid-1-related protein family and uses thereof |
| 06/30/2004 | EP1432444A2 Anti-a-beta antibodies |
| 06/30/2004 | EP1432441A2 Use of hmgb1 for the activation of dendritic cells |
| 06/30/2004 | EP1432433A2 Antagonists |
| 06/30/2004 | EP1432431A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 06/30/2004 | EP1383372A4 Bioluminescent plants and methods of making same |
| 06/30/2004 | EP1235919B1 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| 06/30/2004 | EP1231831A4 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 06/30/2004 | EP1032418B1 Compact epstein-barr virus replicons |
| 06/30/2004 | EP1007712A4 The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
| 06/30/2004 | EP1007637B1 Methods for increasing the efficiency of recombinant aav product |
| 06/30/2004 | EP0915902A4 Transgenic animals expressing artificial epitope-tagged proteins |
| 06/30/2004 | EP0914419B1 Transgenic mice capable of expressing leukemia inhibitory factor |
| 06/30/2004 | EP0862628B1 Receptor and nucleic acid molecule encoding said receptor |
| 06/30/2004 | EP0851876B1 Antisecretory factor peptides regulating pathological permeability changes |
| 06/30/2004 | EP0815125B1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES |
| 06/30/2004 | EP0765385B1 COMPOSITIONS AND METHOD OF STIMULATING THE PROLIFERATION AND DIFFERENTIATION OF HUMAN FETAL AND ADULT PANCREATIC CELLS $i(EX VIVO) |
| 06/30/2004 | EP0686161B1 Novel human beta2 integrin alpha subunit |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509333A Novel neurotrophic factors |
| 06/30/2004 | CN1509330A Polypeptides having cellobiase activity and polynucleotides encoding same |
| 06/30/2004 | CN1509329A Phosphotriesterase from agrobaterium radiobacter P230 |
| 06/30/2004 | CN1509328A Use of opg ligand to modulate immune response |
| 06/30/2004 | CN1509327A CD4+CD25+regulatory T cells from human blood |
| 06/30/2004 | CN1509293A Expression technology for proteins containing hybrid isotype antibody moiety |
| 06/30/2004 | CN1509155A Artificial kidney having function of metabolizing profein and method of constituting same |
| 06/30/2004 | CN1508252A Use of orychophragmus violaceus ODREB2B gene for cultivating drought-tolerant plant |
| 06/30/2004 | CN1508151A Gclq receptor, HIV-laplzo area jointed with same and relative peptide and target-directional antibody |
| 06/30/2004 | CN1507926A Tendon tissue engineered seed cell-hypodermal fibroblast |
| 06/30/2004 | CN1507925A Use of decellularized, decalcitied bone as tissue engineered material |
| 06/30/2004 | CN1155715C Improved transformation method for plants |
| 06/30/2004 | CN1155714C Antifungal proteins, DNA coding therefore, and hosts incorporating same |
| 06/30/2004 | CN1155711C Process for preparing 0-acetylsering, L-cysteine and L-cystein-related products |
| 06/30/2004 | CN1155709C Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof |
| 06/30/2004 | CN1155708C DNA of encoding plasminogen excited protein |
| 06/30/2004 | CN1155699C Cell culture method and gas-filling device for culturing cell |
| 06/30/2004 | CN1155690C Circulation and physiological stress simulating engineering tissue three-dimensional cultivation device |
| 06/29/2004 | US6756527 Inbred corn plant 5750 and seeds thereof |
| 06/29/2004 | US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain |
| 06/29/2004 | US6756491 Receptor polypeptide for use in the treatment of urogenital disorders and cushing's syndrome |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756478 Polypeptide for use in diagnosis and treatment of infections |
| 06/29/2004 | US6756229 Human liver-derived cultured cell lines useful in, for example, analyzing an enzyme participating in the metabolism of xenobiotics or endogenous substrates |
| 06/29/2004 | US6756227 Used as prophylactic and/or therapeutic agents and polypeptides in medicine |
| 06/29/2004 | US6756213 Nucleic acid encoding retinoic acid receptor |
| 06/29/2004 | US6756203 Assays for compounds that modulate rhadino virus LANA action in trans on a unit of rhadino virus DNA to mediate efficient episome persistence |
| 06/29/2004 | US6756051 Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same |
| 06/29/2004 | CA2294476C Semaphorin receptors |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004053499A1 Fluorescent indicator using fret |
| 06/24/2004 | WO2004053163A1 Method for identifying, analyzing and/or cloning nucleic acid isoforms |
| 06/24/2004 | WO2004053144A2 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 06/24/2004 | WO2004053129A1 Methods and means for modulating cellulose biosynthesis in fiber producing plants |
| 06/24/2004 | WO2004053115A1 Magnetism based rapid cell separation |
| 06/24/2004 | WO2004053113A1 In vitro immunization |
| 06/24/2004 | WO2004053096A2 Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 06/24/2004 | WO2004053095A2 In situ maturation of dendritic cells |
| 06/24/2004 | WO2004053084A2 Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases |
| 06/24/2004 | WO2004053080A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
| 06/24/2004 | WO2004053072A2 Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| 06/24/2004 | WO2004053071A2 Method for discovering neurogenic agents |
| 06/24/2004 | WO2004053069A2 PROTECTION OF STEM CELLS FROM CYTOTOXIC AGENTS BY MODULATION OF β-CATENIN SIGNALING PATHWAYS |
| 06/24/2004 | WO2004053057A2 Gene expression systems and recombinant cell lines |
| 06/24/2004 | WO2004052276A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/24/2004 | WO2004052184A2 Genes related to sensitivity and resistance to chemotherapeutic drug treatment |
| 06/24/2004 | WO2004052177A2 Cell-based therapies for ischemia |
| 06/24/2004 | WO2004052093A1 METHOD OF CONSTRUCTING NONHUMAN MAMMAL HAVING RNAi PHENOTYPE |
| 06/24/2004 | WO2004052079A2 Method for programmed differentiation of stem cells |
| 06/24/2004 | WO2004041183A3 Methods of treating pulmonary fibrotic disorders |
| 06/24/2004 | WO2004033627A3 Methods for efficient production of mammalian recombinant proteins |
| 06/24/2004 | WO2004031343A3 Human foreskin cells suitable for culturing stem cells |
| 06/24/2004 | WO2004030706A3 Bioactive implants |
| 06/24/2004 | WO2004025293A3 Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells |
| 06/24/2004 | WO2004024925A3 Collectin-complement activating protein chimeras |
| 06/24/2004 | WO2004022575A3 Bioinformatics analysis of cellular effects of artificial transcription factors |
| 06/24/2004 | WO2004020980A3 Assays for the detection of biliverdin in birds and reptiles |
| 06/24/2004 | WO2004010953A3 Implantable artificial organ devices |
| 06/24/2004 | WO2004007753A3 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 06/24/2004 | WO2004005474A3 A robust, inducible cardiac preferred expression system for transgenesis |
| 06/24/2004 | WO2004000871A3 Thioesterase-related nucleic acid sequences and methods |
| 06/24/2004 | WO2003106478A3 ANTIBODIES THAT BIND alphaE INTEGRIN |
| 06/24/2004 | WO2003097795A3 Constitutively translocating cell line |
| 06/24/2004 | WO2003076631A3 Genetic products differentially expressed in tumors and use thereof |
| 06/24/2004 | WO2003075856A3 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea |
| 06/24/2004 | WO2003068800A3 Isolated peptides which bind to hla molecules and uses thereof |